|
Mylan Inc., which provides products to customers in approximately 150 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies.
Recent Releases
May 17, 2013
Mylan Launches Generic Tricor® Tablets
May 15, 2013
Mylan Launches Generic Zomig® Tablets
View all releases »
Events & Presentations
May 22, 2013 at 9:30 AM ET
UBS 2013 Global Healthcare Conference
View all events & presentations »
|
| Stock Chart |
|
| Stock Quote |
| Mylan Inc. (NASDAQ: MYL) |
| Price: |
31.28 |
| Change: |
- 0.12 |
| Day High: |
31.89 |
| Day Low: |
31.14 |
| Volume: |
4,223,500 |
Delayed at least 20 minutes.
Provided by eSignal. |
|